Nanomedicine & Cancer

According to the World Health Organization (WHO), there will be 15 million new cases of cancer worldwide in 2020. More than 90% of cancer-related deaths occur by the spread of malignant cells to vital organs, a process called metastasis. Academia, Pharmaceutical and biotechnology companies are making substantial research investments in order to develop specific treatments that can destroy primary and secondary tumors, i.e. those resulting from metastasis to other organs. Nanotechnology in cancer treatments is already a reality providing a wide range of new tools and possibilities, from earlier diagnostics and improved imaging to better, more efficient, and more targeted therapies.

    Related Conference of Nanomedicine & Cancer

    June 15-16, 2022

    18th Nanotechnology and Nanomedicine Congress

    Berlin, Germany
    June 28-28, 2022

    25th World Nanotechnology Congress

    Singapore City, Singapore
    July 11-12, 2022

    30th International Conference on Nanomedicine and Nanomaterials

    Singapore City, Singapore
    July 18-19, 2022

    36th International Conference on Neonatology and Perinatology

    Amsterdam, Netherlands
    October 07-08, 2022

    8th Annual Meet on Nanoscience and Nanotechnology

    Zurich, Switzerland
    October 13-14, 2022

    24th Materials Science and Nano Tech Expo

    Osaka, Japan
    October 24-25, 2022

    33rd World Nano Conference

    Dublin, Ireland
    November 08-09, 2022

    3rd World Congress on Nanotechnology and Advanced Materials

    Budapest, Hungary
    November 16-17, 2022

    36th International Conference on Nanotechnology & Expo

    Barcelona, Spain
    December 05-06, 2022

    Applied Nanotechnology Summit

    Paris, France

    Nanomedicine & Cancer Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in